This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataFull dose escalation data show favorable safety profile of ISB 2001 for Multiple Myeloma: Ichnos...
USV Acquires 79% Stake in Wellbeing Nutrition, Values D2C Startup at Rs 1,583 CrSanofi to acquire Blueprint Medicines for up to USD 9.5 billion
NPPA Finally Allows GSK to Discontinue Grisovin FPGSK Linerixibat application for cholestatic pruritus in primary biliary cholangitis patients under...
GSK Pharma: Chinmay Sharma appointed HRBL, Performance Emerging Markets based out of London; Harsh V Trehan named India HR HeadGSK Pharma: Chinmay Sharma appointed HRBL, Performance Emerging Markets based out of London; Harsh V...
Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for DiabetesCDSCO approves Biocon diabetes drug Liraglutide
J.B. Chemicals CFO Narayan Saraf ResignsGranules India Krishnamohan B resigns as Vice President & Head- IT
Alembic Pharma gets four USFDA observations for Panelav facilityAlembic Pharma gets four USFDA observations for Panelav facility
Cipla appoints Prabhakaran Balakrishnan Nair as Global Chief Manufacturing OfficerCipla appoints Prabhakaran Balakrishnan Nair as Global Chief Manufacturing Officer
CDSCO Panel Approves BE Study for Alkems Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III PlanCDSCO Panel Approves BE Study for Alkem's Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised...
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresZydus Lifesciences Rifaximin Tablets bags USFDA tentative nod for irritable bowel syndrome with...
Dr Reddy gets CDSCO Panel nod for oral semaglutideDr Reddy's Gets Rs 2,395 Crore Tax Notice Over Merger, Says No Material Impact
Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP NormsUSFDA successfully completes inspection at Piramal Pharma Canada facility
X